PROSPECTS FOR OF INHIBITORS OF TUMOR NECROSIS FACTOR-Α IN  THE TREATMENT OF ANKYLOSING SPONDILOARTHRITIS

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10834

Title:	PROSPECTS FOR OF INHIBITORS OF TUMOR NECROSIS FACTOR-Α IN THE TREATMENT OF ANKYLOSING SPONDILOARTHRITIS
Authors:	Pulatova Sh.B., Abduazizova N.
Keywords:	ankylosing spondylitis; tumor necrosis factor-α inhibitors; efficiency; safety
Issue Date:	Aug-2023
Publisher:	Asian journal of Pharmaceutical and biological research 2231-2218
Series/Report no.:	Volume 12 Issue 2;
Abstract:	A review of recommendations for the use of tumor necrosis factor α (TNF-α) inhibitors in patients with ankylosing spondylitis (AS) is presented. The data on the efficacy of TNF-α in patients with AS are presented. On the basis of international and domestic recommendations, ndications for the appointment of this therapy, criteria for assessing its effectiveness and safety are formulated.
URI:	http://repository.tma.uz/xmlui/handle/1/10834
ISSN:	2231-2218
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Volume 12 Issue 2 куз.pdf		364.28 kB	Adobe PDF	View/Open

DSpace JSPUI